W o r l d . C r y p t o . G l o b a l

Loading

Welcome at World Crypto Global. This portal is packed with useful content and resources to built out your own crypto skills. WorldCrypto is a site member of Gabriel Vega Network.

Contact Info

Get Free Coins
img
img

CATEGORY: biotech

Biotech Stock Pasithea Therapeutics Corp. (NASDAQ: KTTA) Soars on Positive Data from Phase 1 Clinical Trials
United States
Source: Investorideas.com newswire, breaking stock market
Sep 27, 2024 07:05

Biotech Stock Pasithea Therapeutics Corp. (NASDAQ: KTTA) Soars on Positive Data from Phase 1 Clinical Trials

September 26, 2024 (Investorideas.com Newswire) Investorideas.com (www.investorideas.com), a go-to platform for big investing ideas for stock traders, including biotech stocks reports on trading and news for Pasithea Therapeutics Corp. (NASDAQ: KTTA), a clinical-stage biotechnology company developing PAS-004, a next-generation macrocyclic MEK inhibitor, for the treatment of neurofibromatosis type 1 (NF1) and other cancer indications.

View Details View Details
Wave Life Sciences Ltd. (Nasdaq: WVE) Gains on Clinical Trial News
United States
Source: Investorideas.com newswire, breaking stock market
Sep 25, 2024 07:00

Wave Life Sciences Ltd. (Nasdaq: WVE) Gains on Clinical Trial News

September 24, 2024 (Investorideas.com Newswire) Investorideas.com (www.investorideas.com), a go-to platform for big investing ideas for stock traders, including biotech stocks reports on trading and news for Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health.

View Details View Details
Seelos Therapeutics, Inc. (Nasdaq: SEEL) Soars on update for its SLS-002 (intranasal racemic ketamine) for PTSD
United States
Source: Investorideas.com newswire, breaking stock market
Sep 25, 2024 07:00

Seelos Therapeutics, Inc. (Nasdaq: SEEL) Soars on update for its SLS-002 (intranasal racemic ketamine) for PTSD

September 24, 2024 (Investorideas.com Newswire) Investorideas.com (www.investorideas.com), a go-to platform for big investing ideas for stock traders, including biotech technology stocks reports on trading and news for Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases.

View Details View Details
Stocks to Watch Battling the Opioid Epidemic
United States
Source: Investorideas.com newswire, breaking stock market
Sep 21, 2024 07:00

Stocks to Watch Battling the Opioid Epidemic

September 20, 2024 (Investorideas.com Newswire) Investorideas.com (www.investorideas.com), a go-to investing platform covering cannabis stocks releases an industry snapshot looking at the battle against dangerous drugs, including fentanyl, featuring Greenlane Holdings, Inc. (NASDAQ:GNLN), one of the premier global sellers of premium cannabis accessories, child-resistant packaging, and specialty vaporization products.

View Details View Details
Breaking Medical Technology News: Aethlon (NASDAQ: AEMD) Receives Ethics Committee Approval for Hemopurifier Cancer Trial in India
United States
Source: Investorideas.com newswire, breaking stock market
Sep 20, 2024 07:00

Breaking Medical Technology News: Aethlon (NASDAQ: AEMD) Receives Ethics Committee Approval for Hemopurifier Cancer Trial in India

SAN DIEGO - September 19, 2024 (Investorideas.com Newswire) Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life threatening infectious diseases, today announced that, on September 9, 2024, the Medanta Institutional Ethics Committee (MIEC) granted full ethics approval for Aethlon's safety, feasibility and dose-finding clinical trial of the Hemopurifier in cancer patients with solid tumors who have stable or progressive disease during anti-PD-1 monotherapy treatment, such as Keytruda (pembrolizumab) or Opdivo (nivolumab) (AEMD-2022-06 Hemopurifier Study).

View Details View Details
Immunotherapy Clinical Trial News - Stocks to Watch
United States
Source: Investorideas.com newswire, breaking stock market
Sep 20, 2024 07:00

Immunotherapy Clinical Trial News - Stocks to Watch

September 19, 2024 (Investorideas.com Newswire) Investorideas.com (www.investorideas.com), a go-to investing platform, releases the second of a two-part series looking at news and developments for the treatment of cancer and solid tumors focusing on immunotherapy, featuring Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening viral infections.

View Details View Details
Breaking Medical Technology News: Aethlon Medical (NASDAQ: AEMD) to Present at Virtual Investor Conferences in September
United States
Source: Investorideas.com newswire, breaking stock market
Sep 18, 2024 07:00

Breaking Medical Technology News: Aethlon Medical (NASDAQ: AEMD) to Present at Virtual Investor Conferences in September

SAN DIEGO - September 17, 2024 (Investorideas.com Newswire) Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today announced that management will present at the following virtual investor conferences in September

View Details View Details
Cancer's Solid Tumors Market - the Stocks to Watch
United States
Source: Investorideas.com newswire, breaking stock market
Sep 18, 2024 07:00

Cancer's Solid Tumors Market - the Stocks to Watch

September 17, 2024 (Investorideas.com Newswire) Stocks mentioned-Aethlon Medical, Inc. (Nasdaq: AEMD), Immuneering (Nasdaq: IMRX), Merck (NYSE: MRK), AstraZeneca (Nasdaq: AZN) Roche (OTCQX: RHHBY).

View Details View Details
Breaking Medical Technology News: Aethlon Medical (NASDAQ: AEMD) Announces Activation of Royal Adelaide Hospital to Begin Patient Screening and Enrollment in Hemopurifier Cancer Trial
United States
Source: Investorideas.com newswire, breaking stock market
Sep 17, 2024 07:00

Breaking Medical Technology News: Aethlon Medical (NASDAQ: AEMD) Announces Activation of Royal Adelaide Hospital to Begin Patient Screening and Enrollment in Hemopurifier Cancer Trial

SAN DIEGO - September 16, 2024 (Investorideas.com Newswire) Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today announced that the Cancer Clinical Trial Unit at Royal Adelaide Hospital was activated on September 10, 2024 to begin screening and enrolling patients in its safety, feasibility and dose-finding clinical trial of the Hemopurifier in patients with solid tumors who have stable or progressive disease during anti-PD-1 monotherapy treatment, such as Keytruda (pembrolizumab) or Opdivo (nivolumab) (AEMD-2022-06 Hemopurifier Study).

View Details View Details
Breaking Medical Technology News: Aethlon Medical (NASDAQ: AEMD) to Present at the Life Sciences Investor Forum September 19th
United States
Source: Investorideas.com newswire, breaking stock market
Sep 14, 2024 07:00

Breaking Medical Technology News: Aethlon Medical (NASDAQ: AEMD) to Present at the Life Sciences Investor Forum September 19th

SAN DIEGO - September 13, 2024 (Investorideas.com Newswire) Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, is pleased to announce that Jim Frakes, interim CEO and CFO and Steve LaRosa, Chief Medical Officer, will present live at the Life Sciences Investor Forum, hosted by VirtualInvestorConferences.com, on September 19th 2024.

View Details View Details
Huge Gains, Huge Volume for Biopharma Stock FSD Pharma Inc (NASDAQ: HUGE) (CSE: HUGE)
United States
Source: Investorideas.com newswire, breaking stock market
Aug 10, 2024 07:00

Huge Gains, Huge Volume for Biopharma Stock FSD Pharma Inc (NASDAQ: HUGE) (CSE: HUGE)

August 9, 2024 (Investorideas.com Newswire) Investorideas.com (www.investorideas.com), a go-to platform for big investing ideas, including biotech stocks reports on trading for FSD Pharma Inc (NASDAQ:HUGE) (CSE:HUGE) (FRA:0K9A), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development.

View Details View Details
VBI Vaccines Inc. (Nasdaq: VBIV) Rises from the Ashes and is NASDAQ Top Percentage Gainer
United States
Source: Investorideas.com newswire, breaking stock market
Aug 07, 2024 07:00

VBI Vaccines Inc. (Nasdaq: VBIV) Rises from the Ashes and is NASDAQ Top Percentage Gainer

August 6, 2024 (Investorideas.com Newswire) Investorideas.com, a go-to platform for big investing ideas, including biotech stocks reports on trading for VBI Vaccines Inc. (Nasdaq: VBIV), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease.

View Details View Details
The GLP-1 Products and Players - Stocks to Watch
United States
Source: Investorideas.com newswire, breaking stock market
Aug 29, 2024 07:00

The GLP-1 Products and Players - Stocks to Watch

August 28, 2024 (Investorideas.com Newswire) Investorideas.com (www.investorideas.com), a go-to investing platform covering health and wellness and biotech stocks issues a snapshot looking at news and developments for the global GLP-1 receptor agonist market, featuring new player in the market, Integrated Ventures, Inc. (OTCQB: INTV).

View Details View Details
Breaking Medical Technology News: Aethlon Medical (NASDAQ: AEMD) Announces Publication of Preclinical Data Showing Ability of the Hemopurifier to Remove Extracellular Vesicles and microRNAs from Renal Perfusates Following Controlled Oxygenated Rewarming of Discarded Donor Kidneys
United States
Source: Investorideas.com newswire, breaking stock market
Aug 28, 2024 07:00

Breaking Medical Technology News: Aethlon Medical (NASDAQ: AEMD) Announces Publication of Preclinical Data Showing Ability of the Hemopurifier to Remove Extracellular Vesicles and microRNAs from Renal Perfusates Following Controlled Oxygenated Rewarming of Discarded Donor Kidneys

SAN DIEGO - August 27, 2024 (Investorideas.com Newswire) Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today announced the publication in preprint of an in vitro study in bioRxiv on August 24, 2024, entitled, "The Hemopurifier Removes Extracellular Vesicles and microRNAs From Renal Perfusates Following Controlled Oxygenated Rewarming of Discarded Donor Kidneys."

View Details View Details
Trinity Biotech plc (Nasdaq: TRIB) Spikes on Orders for TrinScreen HIV
United States
Source: Investorideas.com newswire, breaking stock market
Aug 28, 2024 07:00

Trinity Biotech plc (Nasdaq: TRIB) Spikes on Orders for TrinScreen HIV

August 27, 2024 (Investorideas.com Newswire) Investorideas.com (www.investorideas.com), a go-to platform for big investing ideas, including biotech and pharma stocks reports on trading and news for Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors.

View Details View Details
Virax Biolabs Group Limited (NASDAQ: VRAX) - The Viral Disease Rally Continues
United States
Source: Investorideas.com newswire, breaking stock market
Aug 24, 2024 07:00

Virax Biolabs Group Limited (NASDAQ: VRAX) - The Viral Disease Rally Continues

August 23, 2024 (Investorideas.com Newswire) Investorideas.com (www.investorideas.com), a go-to platform for big investing ideas, including biotech and pharma stocks reports on trading and news for Virax Biolabs Group Limited (NASDAQ: VRAX), an innovative biotechnology company focused on the detection of immune responses and diagnosis of viral diseases.

View Details View Details
The Mpox Stock Rally Continues - Virax Biolabs Group (NASDAQ: VRAX) Sees Big Gains
United States
Source: Investorideas.com newswire, breaking stock market
Aug 22, 2024 07:00

The Mpox Stock Rally Continues - Virax Biolabs Group (NASDAQ: VRAX) Sees Big Gains

August 21, 2024 (Investorideas.com Newswire) Investorideas.com (www.investorideas.com), a go-to platform for big investing ideas, including biotech and pharma stocks reports on trading and news for Virax Biolabs Group Limited (NASDAQ: VRAX), an innovative biotechnology company focused on the detection of immune responses and diagnosis of viral diseases.

View Details View Details
Pharma Stock InMed Pharmaceuticals Inc. (NASDAQ: INM) Gains on INM-901 Oral Drug News
United States
Source: Investorideas.com newswire, breaking stock market
Aug 21, 2024 07:00

Pharma Stock InMed Pharmaceuticals Inc. (NASDAQ: INM) Gains on INM-901 Oral Drug News

August 20, 2024 (Investorideas.com Newswire) Investorideas.com (www.investorideas.com), a go-to platform for big investing ideas, including biotech and pharma stocks reports on trading and news for InMed Pharmaceuticals Inc. (NASDAQ: INM), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseases with high unmet medical needs.

View Details View Details
Virax Biolabs Group Limited (NASDAQ: VRAX) and the retail investor mpox stocks mania
United States
Source: Investorideas.com newswire, breaking stock market
Aug 20, 2024 07:00

Virax Biolabs Group Limited (NASDAQ: VRAX) and the retail investor mpox stocks mania

August 19, 2024 (Investorideas.com Newswire) Investorideas.com (www.investorideas.com), a go-to platform for big investing ideas, including biotech and pharma stocks reports on trading and news for Virax Biolabs Group Limited (NASDAQ: VRAX), an innovative biotechnology company focused on the detection of immune responses and diagnosis of viral diseases.

View Details View Details
Top 20 global biopharmaceutical companies report 4.3% growth in market capitalization in Q2 2024
United States
Source: Investorideas.com newswire, breaking stock market
Aug 17, 2024 07:00

Top 20 global biopharmaceutical companies report 4.3% growth in market capitalization in Q2 2024

August 16, 2024 (Investorideas.com Newswire) The biopharmaceutical industry remained resilient in the second quarter (Q2) of 2024 as global markets and investor optimism improved with anticipation of a potential interest rate cut from the US Federal Reserve.

View Details View Details

Recent Crypto News

May 23, 2025 05:10   
Worldcoin Jumps 10% After World Foundation Raises $135M Through Early Backers
May 23, 2025 05:10   
Michael Saylors Strategy (MSTR) Opens $2.1B ATM Program for Strife Preferred Stock 
May 23, 2025 05:10   
Despite Record Prices, Bitcoin Selling Pressure Craters as Investors Hold Firm, Cryptoquant Reports
May 23, 2025 04:25   
Bitcoin Overtakes Amazon in Total Market Cap, as Supporters Eye even Bigger Targets...
May 23, 2025 04:20   
Ethereum (ETH) Price Prediction 2025, 2026-2030
May 23, 2025 04:20   
Best Cryptos To Invest in for Huge Returns In 2025: Solana, Cardano, Unilabs
May 23, 2025 04:20   
The Rise of AI-Integrated Cryptocurrencies
May 23, 2025 04:20   
Unilabs Finance Hits $800,000 After Referral System Launch, While Litecoin and Cardano Explode
May 23, 2025 04:20   
U.S. Senate Advances GENIUS Act: A Game-Changer for Stablecoin Regulation
May 23, 2025 04:20   
Bitcoin (BTC) Price Prediction 2025, 2026-2030 
Your 1,000 Free WCG Coins Start Here
Your Crypto Gateway

Claim 1,000
Free WCG Coins

World Crypto Global opens the door to digital freedom for everyone.
Manage your free WCG Coins securely—where simplicity meets global accessibility.

Get Start Today How It’s Works

11 bn

FREE CRYPTO COINS

8.9 bn

AVAILABLE FOR RESERVATION

2.1 bn+

ALREADY ALLOCATED

× WCG Coin

🎉 Get 1,000 WCG Coins

No fees. No catch. Your crypto journey starts here.